Notable Put Options Activity in Keryx Biopharmaceuticals

Shares of Keryx Biopharmaceuticals

are lower on the session by 0.41%, currently trading at $2.40. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are focusing on puts today. The strike seeing the heaviest action is the January 2012 $2.50 put, which has traded 1,500 times on open interest of 12,750 contracts. Put volume is outpacing call volume by 2 to 1. Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.